Status:
COMPLETED
Spironolactone Plus Metformin in Polycystic Ovary Syndrome
Lead Sponsor:
University Magna Graecia
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
16-35 years
Phase:
NA
Brief Summary
The investigators examined whether a combined therapy with low-dose spironolactone plus metformin is more effective than metformin alone in 52 overweight/obese Polycystic Ovary Syndrome (PCOS) patient...
Detailed Description
In the present prospective, randomized study, we evaluated the efficacy of a combined therapy with metformin and low-dose spironolactone as compared to metformin alone on the clinical and endocrine-me...
Eligibility Criteria
Inclusion
- Overweight/obese patients with PCOS
Exclusion
- Other causes of hyperandrogenism and
- Use of drugs including:
- oral contraceptive
- anti-hypertensive agents
- anti-diabetic drugs
- agents for weight loss
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT01526616
Start Date
May 1 2010
End Date
July 1 2011
Last Update
February 6 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.